Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001104659-17-031128
Filing Date
2017-05-09
Accepted
2017-05-09 16:02:02
Documents
37
Period of Report
2017-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q a17-8893_110q.htm 10-Q 937061
2 EX-31.1 a17-8893_1ex31d1.htm EX-31.1 13506
3 EX-31.2 a17-8893_1ex31d2.htm EX-31.2 12363
4 EX-32.1 a17-8893_1ex32d1.htm EX-32.1 5858
5 EX-32.2 a17-8893_1ex32d2.htm EX-32.2 5882
  Complete submission text file 0001104659-17-031128.txt   3835575

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE DOCUMENT gern-20170331.xml EX-101.INS 950135
7 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT gern-20170331.xsd EX-101.SCH 21869
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT gern-20170331_cal.xml EX-101.CAL 36134
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT gern-20170331_def.xml EX-101.DEF 71278
10 XBRL TAXONOMY EXTENSION LABELS LINKBASE DOCUMENT gern-20170331_lab.xml EX-101.LAB 239275
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT gern-20170331_pre.xml EX-101.PRE 149300
Mailing Address 149 COMMONWEALTH DRIVE SUITE 2070 MENLO PARK CA 94025
Business Address 149 COMMONWEALTH DRIVE SUITE 2070 MENLO PARK CA 94025 6504737700
GERON CORP (Filer) CIK: 0000886744 (see all company filings)

EIN.: 752287752 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-20859 | Film No.: 17826303
SIC: 2834 Pharmaceutical Preparations